Concentric Capital Strategies’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-14,288	Closed	-$905K	–	351
2024 Q3	$905K	Sell	14,288 -29,597	-67%	-$1.87M	0.04%	218
2024 Q2	$2.33M	Buy	43,885 +24,161	+122%	+$1.28M	0.12%	157
2024 Q1	$1.62M	Buy	+19,724	New	+$1.62M	0.09%	199